About Vectorite Biomedical
Vectorite Biomedical is a publicly listed company based in Taipei (Taiwan) founded in 2004. Immune cell therapies for cancer and infectious diseases are developed. Its focus areas include Life Sciences, Oncology, Drugs and Diversified.
Company details
Vectorite Biomedical, founded in 2004, operates as a public biotech company in Taipei, Taiwan. Research and development of adoptive cell therapy technologies are focused on cancer and infectious diseases. An immune cell bank is maintained for the storage of adult healthy cells. Activities are centered in the biotechnology sector, with emphasis on therapeutic applications.
- Headquarters Taipei, Taiwan
- Stage Public
- SectorsHealthcare
- Website vectorite.com.tw
- Social Facebook
- Legal Name Vectorite Biomedical, Inc.
- Annual Revenue$61.41 M6.29as on Dec 31, 2025
- Net Profit$96.17 Mas on Dec 31, 2025
- EBITDA-$13.77 M20as on Dec 31, 2025
IPO & Listings of Vectorite Biomedical
Vectorite Biomedical is a publicly listed company on the TPEX with ticker symbol 4170 in Taiwan, operating in the Transportation sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date28 Dec 2023
- Listed onTT: 4170
- Listed entityVectorite Biomedical, Inc.
- Exchange sectorTransportation
- ISINTW0004170006
- Share price12.55 TWD · 2026-10-14
- Market capitalisation549,330,701.00 TWD
- Price to earnings4.7
- EPS (diluted, trailing year)2.69 TWD
- Volume (last session)3
Financials of Vectorite Biomedical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 61.4M TWD | 96.2M TWD | -13.8M TWD |
| 2024 | 57.8M TWD | -40.0M TWD | -17.2M TWD |
| 2023 | 55.9M TWD | -6.6M TWD | -7.0M TWD |
| 2022 | 42.9M TWD | -26.4M TWD | -21.7M TWD |
| 2021 | 28.8M TWD | 8.4M TWD | -25.9M TWD |
Detailed financial statements for Vectorite Biomedical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of Vectorite Biomedical
The website of Vectorite Biomedical (vectorite.com.tw) receives about 1.7K visits a month.
- Monthly visits1.7K
▲ 33.3% vs previous month
Websites whose visitors overlap most with Vectorite Biomedical. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
sle.org.tw | sle.org.tw | 100% | #11,933,534 | – | |
cisc.twbbs.org | cisc.twbbs.org | 100% | – | ||
canceraway.org.tw | canceraway.org.tw | 100% | #418,978 | – | |
eck.org.tw | eck.org.tw | 100% | #292,734 | – | |
raphaelmedical.com.tw | raphaelmedical.com.tw | 100% | #2,652,243 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 10 similar websites and full traffic analytics for Vectorite Biomedical
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 10 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Vectorite Biomedical
Complete news archive for Vectorite Biomedical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vectorite Biomedical
Vectorite Biomedical was founded in 2004.
Vectorite Biomedical is headquartered in Taipei, Taiwan.
Vectorite Biomedical, founded in 2004, operates as a public biotech company in Taipei, Taiwan. Research and development of adoptive cell therapy technologies are focused on cancer and infectious diseases. An immune cell bank is maintained for the storage of adult healthy cells. Activities are centered in the biotechnology sector, with emphasis on therapeutic applications.
Yes, Vectorite Biomedical is publicly traded on TPEX under the ticker symbol 4170.